Objective: To evaluate the effectiveness of The Ultrasound-Guided Core Needle Biopsy (US-CNB) technique in a group of patients with suspected cervical lymph nodes on clinic and ultrasound.
Subjects and Methods: This cross-sectional descriptive study on 201 patients with suspected cervical lymph nodes underwent US-CNB at the Department of Diagnostic Ultrasound of the 108 Military Central Hospital from January 2022 to September 2023.
Results: The patient’s mean age was 55.4 years old, with a high proportion of men (71.1%); 88.1% of patients were diagnosed from the first US-CNB and did not need open biopsy and 11.9% of patients need a second US-CNB or open biopsy for pathology. The sensitivity, specificity and accuracy of cervical lymph node biopsy under ultrasound were 93.4%, 100% and 95.5%, respectively. The proportions of the groups of metastatic lymph nodes, lymphoma, and benign lymph nodes were 52.2%, 15.9% and 31.9%, respectively. In the lymphoma group, the accuracy of technique was 65.6%. 4 patients (2%) had mild bleeding in the lymph nodes and along the biopsy needle. There were no severe complications such as death, severe bleeding, infection, or nerve damage.
Conclusion: Ultrasound-guided biopsy in cervical lymph node is a safe and effective method of diagnosing abnormal lymph nodes in the neck, with high accuracy and minimal invasiveness.